Literature DB >> 2596349

A factor analytical study of the Comprehensive Psychopathological Rating Scale among patients with anxiety and depressive disorders.

E W Martinsen1, S Friis, A Hoffart.   

Abstract

A sample of 136 inpatients, meeting the DSM-III-R criteria for anxiety and/or unipolar depressive disorders, were rated on the 37 CPRS items designed for nonpsychotic disorders. By factor analysis we identified 2 indices: a 12-item depression index and a 7-item anxiety index. The indices proved to have good internal consistency and interrater reliability. They differentiated well between patients with anxiety and those with depressive disorders, and among subgroups of anxiety and depression. Our depression index may represent a slight improvement in specificity compared with previously suggested depression indices. Our main finding is the identification of an anxiety index with good psychometric properties.

Entities:  

Mesh:

Year:  1989        PMID: 2596349     DOI: 10.1111/j.1600-0447.1989.tb03011.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  Psychosocial morbidity in acromegaly: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Ramma Malhotra
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

2.  Psychosocial morbidity in Cushing disease: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Rama Malhotra
Journal:  Endocrine       Date:  2009-04-09       Impact factor: 3.633

3.  Measuring common mental disorders in women in Ethiopia: reliability and construct validity of the comprehensive psychopathological rating scale.

Authors:  Charlotte Hanlon; Girmay Medhin; Atalay Alem; Mesfin Araya; Abdulreshid Abdulahi; Markos Tesfaye; Dawit Wondimagegn; Hassan Taha; Birke Anbesse; Yonas Baheretibeb; Michael Dewey; Martin Prince
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-04-24       Impact factor: 4.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.